Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 7
Submit an article Journal homepage
18
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Interferon Alfa-2b Alone or Combined with Recombinant Granulocyte-Macrophage Colony-Stimulating Factor as Treatment of Chronic Hepatitis C

K. Grønbaek
,
H. Bygum Krarup
,
H. Ring-Larsen
,
O. Schaffalitzky De Muckadell
,
A. Møller
,
P. Schlichting
&
M. Vyberg
 show all
Pages 840-844 | Published online: 08 Jul 2009

  • Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991;14:969-74.
  • Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-3.
  • Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825-32.
  • McHutchison JG, Gordon SC, Schiff ER, Shiftman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
  • Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic hepatitis infection with hepatitis C virus. Lancet 1998;352:1426-32.
  • Reichard O, Norkrans G, Frydén A, Braconier JH, Sönnerborg A, Weiland O, for the Swedish Study Group. Randomised, doubleblind, placebo-controlled trial of interferon a-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351:83-7.
  • Ruef C, Coleman DL. Granulocyte-macrophage colony-stimulating factor: pleotropic cytokine with potential clinical usefulness. Rev Infect Dis 1990;12:41-62.
  • Weisbart RH, Golde DW. Physiology of granulocyte and macrophage colony-stimulating factor in host defense. Hematol Oncol Clin North Am 1989;3:401-9.
  • Gasson JC. Molecular physiology of granulocyte macrophage colony-stimulating factor. Blood 1991;77:1131-45.
  • Monroy RL, Davis TA, MacVittie TJ. Granulocyte-macrophage colony-stimulating factor: more than hemopoietin. Clin Immunol Immunopathol 1990;54:333-46.
  • Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Lab Invest 1998-58:415-22.
  • Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, Von Der Lippe B, et al. Interferon-a2b therapy in low-activity hepatitis C: a pilot study. Scand J Gastroenterol 1997;32:1256-60.
  • Krarup HB, Møller JM, Christensen PB, Fuglsang T, Ingerselv J, Arnfred T, et al. Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups. J Viral Hepat 2000;7:435-9.
  • Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
  • Martin J, Bosch O, Moraleda G, Bartolome J, Quiroga JA, Carreno V. Pilot study of recombinant human granulocytemacrophage colony-stimulating factor in the treatment of chronic hepatitis B. Hepatology 1993;18:775-80.
  • Carreno V, Martin J, Pardo M, Brotons A, Anchia P, Navas S, et al. Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis C. Cytokine 2000;12:165-70.
  • Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ. Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C. J Hepatol 1998;28:382-9.
  • Carreno V, Parra A, Navas S, Quiroga JA. Granulocytemacrophage colony-stimulating factor as adjuvant therapy for interferon a treatment of chronic hepatitis C. Cytokine 1996; 8:318-22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.